Peregrine Pharmaceuticals

PPHM

PPHM
Peregrine Pharmaceuticals Stock Quote
BATS BZX Real Time Price as of View Interactive PPHM Charts

A biopharmaceutical company with a portfolio of clinical stage and pre-clinical product candidates using monoclonal antibodies for the treatment of cancer and viral diseases.

News & Analysis: Peregrine Pharmaceuticals

The Fool has written over 100 articles on Peregrine Pharmaceuticals.

All









Peregrine Pharmaceuticals Q4 Earnings Preview

Peregrine Pharmaceuticals is set to report its fourth-quarter and full-year results on Tuesday, July 14. Here are a few factors that investors would be wise to pay attention to when the results are released.



Interactive Chart